MORE DIAGNOSTICS Whole Blood Matrix is intended to be used as a whole blood matrix and zero level control product to check calibration in chemistry analyzers which measure everolimus,…
MORE DIAGNOSTICS Whole Blood Matrix is intended to be used as a whole blood matrix and zero level control product to check calibration in chemistry analyzers which measure everolimus, rapamycin (sirolimus), tacrolimus, and cyclosporine.
Who Else Makes It
Registered in Jiangsu.
Record
Regulatory record for Whole Blood Matrix | Listed by | More Diagnostics Inc., United States |
| FDA product code | JJY |
| Device type | Multi-Analyte Controls, All Kinds (Assayed) |
| Device class | Class 1 |
| Regulation | 21 CFR 862.1660 |
| Establishment | Manufacturer |
| Premarket notification | Exempt |
| Record published | 2020-06-17 |
Specifications
Specifications | MRI safety | Labeling does not contain MRI Safety Information |
| Single use | Yes |
| Prescription | Prescription only |
| Label carries | lot or batch number, expiry date, manufacturing date |
| Storage | Storage environment temperature up to -14 °C |
Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.